image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

NMC Health - Raises EBITDA guidance for FY'18

December 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • NMC
  • Price:
  • 3468p
Having surged from our highlighted price of 363p in December ‘13 to an amazing intra-day high of over £43, it was inevitable the shares would re-trace. Nevertheless, NMC has announced at its CMD that following “positive developments in the second half of 2018” it has increased forecast guidance for revenue growth by 2% to 24%. EBITDA guidance is raised from US$465m to US$480m.It also said 2019 guidance is for 22-24% revenue growth and EBITDA to increase by 18-20%. These would have been 13% and 15% respectively if stripping out assets /acquisitions purchased this year.In a new note, broker Berenberg says Dubai’s healthcare demand is high warranting significant expansion in hospital bed numbers; the last 6-7 quarters have seen ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe